• 제목/요약/키워드: Phospho-$\beta$-galactosidase gene

검색결과 4건 처리시간 0.016초

Lactobacillus casei 의 Phospho-$\beta$-galactosidase 유전자의 지도작성과 Escherichia coli 내에서의 발현 (Mapping of Gene Encoding Phospho-$\beta$-galactosidase from Lactobacillus casei and its Expression in Escherichea coli)

  • 박정희;문경희;민경희
    • 미생물학회지
    • /
    • 제30권6호
    • /
    • pp.539-545
    • /
    • 1992
  • Lactobacillus casei SM-M1 의 플라스미드로부터 phospho-$\beta$-galactosidase gene 을 갖는 DNA 를 E. coli 에 클로닝한 pPLac15(13kb) 의 재조합 플라스미드를 제조하였다.(15). pPLac15 DNA 를 분리하여 제한효소로 처리하여 제한효소 지도를 작성하였다. Phospho-$\beta$-galactosidase 유전자의 발현을 높이기 위하여 lac promoter 를 가진 pUC18 의 PstI 위치에 클닝하여 pPLac18 을 제조하였으며, 이것을 다시 EcoRI 으로 절단하여 pUC 18 에 클로닝하여 얻은 pPLac23 (7.6 kb) 를 얻었다. Phospho-$\beta$-galactosidase 효소활성은 pPLac23 의 형질전환주인 E. coli SW-23 에서는 pPLac15 를 가진 형질전환주인 E. coli SW-15 보다 약 1.8 배의 효소의 활성을 나타내었으며 pPLac18 을 가진 E. coli SW-18 보다는 약간 높은 활성을 나타내었다.

  • PDF

Lactobacillus casei의 phospho-$\beta$-galactosidase 유전자의 대장균내 분자클로닝 (Molecular cloning of phospho-$\beta$-galactosidase gene of lactobacillus casei in escherichia coli)

  • 문경희;박정희;최순영;이유미;김태한;김연수;민경희
    • 미생물학회지
    • /
    • 제27권3호
    • /
    • pp.188-193
    • /
    • 1989
  • Gene for lactose catabolism in Lactobacillus casei SW-M1 was encoded by a 60Kb metabolic plasmid. A derivative of only 10kb, pPlac 15 of recombinant plasmid, was constructed by introducing into pBR322 and was cloned into E. coli using restriction endonuclease Pst I. A 10kb insery DNA in plasmid pBR322 was identified as a gene encoded phospho-$\beta$-galactosidase by the determination of enzyme activity. Phospho-$\beta$-galactosidase was apparently expressed in E. coli. The enzyme activities of cell-free extract from transformant E. coli HB101 carrying pPLac 15 DNA were not different from that of L. casei as a donor strain on the basis of enzyme properites. However, specific activity of phospho-$\beta$-galactosidase in the cloned strain with Lac $Y^{-}$ phenotype of E. coli HB101 was lower than that in L. casei strain.

  • PDF

플라스미드에 존재하는 lactobacillus casei의 phospho-$\beta$-galactosidases 유전자 (Phospho-$\beta$-galactosidase gene located on plasmid in lactobacillus casei)

  • 문경희;박정희;최순영;이유미;김태한;하영칠;민경희
    • 미생물학회지
    • /
    • 제27권3호
    • /
    • pp.181-187
    • /
    • 1989
  • Lactobacillus casei SW-M1으로부터 lactose 이용 pPLac Plasmid를 분리하였다. 이 plasmid에 lactose이용 유전자가 존재하는지를 확이하기 위하여 plasmid curing을 실시한 결과, acriflavin 8mg/ml 과 11 mg/ml EtBr를 처리한 후 , 3차 접종 배양의 경우에 curing 빈도가 가장 높았다. Lac와 plasmid가 cured 된 $Lac^{+}$strain의 당 이용능을 조사한 결고, glucose lactosidasedldydsmd은 불변이나, lactosedldydsmd만이 $Lac^{+}$strain에서 감소하였다 pPLac plasmid의 lactose 분해능은 $\beta$-galactosidase 에 의한 것이 아니고, phospho-$\beta$-galactosidase 에 의한 것으로 확인되었다. $Lac^{+}$strain의 carbohydrate가 막투과시 PTS과 관련이 있는가를 조사한 결과ㅏ lactose-PTS가 가장 활성이 높았으며, 그 다음이 galactose-PTS, glucose-PTS 로 나타났다. 그러므로 lactose는 lactose-PTS(lactose-phosphotransferase system)에 의하여 glucose와 galactose-6-phosphate로 분해됨을 알 수 있었다. Phospho-$\beta$-galactosidase의 induction 실험에서는 galactoserk 가장 높은 induction 효과를 보여 주었으며, lactose와 glucose는 높은 수준의 induction을 나타내었으며, IPTG는 induction 효과가 없었다. Glucosedh lactose 배지에서 L. casie는 diauxic growth나 phospho-$\beta$-galactosidase합성을 조사한 결과, catabolite repression을 받지 않는 것으로 나타났다.

  • PDF

Fermented Ginseng Attenuates Hepatic Lipid Accumulation and Hyperglycemia through AMPK Activation

  • Kim, Do-Yeon;Park, Jong-Seok;Yuan, Hai-Dan;Chung, Sung-Hyun
    • Food Science and Biotechnology
    • /
    • 제18권1호
    • /
    • pp.172-178
    • /
    • 2009
  • Fermented ginseng (FG) is an ethanol extract of ginseng radix processed with $\beta$-galactosidase. It was hypothesized that FG may exert anti-hyperlipidemic and anti-diabetic activities through modulating AMP-activated protein kinase (AMPK) in HepG2 human hepatoma cells. In this study, we showed that AMPK phosphorylation was stimulated by FG. These effects were abolished by pretreatment with an AMPK inhibitor, compound C. In addition, FG regulated the expression of genes associated with lipogenesis and lipolysis, thus causing suppression of hepatic triglyceride accumulation. In vivo study using db/db mice, FG reduced fasting plasma glucose, HbAlc, and insulin resistance index, when compared to diabetic control. FG also increased the phospho-AMPK and glucose transporter 4 (GLUT4) expressions in liver and skeletal muscle, respectively. In liver, expressions of lipogenic gene were decreased whereas expressions of lipolytic genes were induced, when compared to diabetic control. Taken together, we may suggest that FG ameliorates hyperglycemia and hyperlipidemia through activation of AMPK and could be developed as a health functional food or therapeutic agent for type 2 diabetic patients.